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journal homepage: www.e- jmii .comLETTER TO THE EDITORCo-occurrence of Leriche syndrome and
antiphospholipid syndrome in a man with
refractory ulcers of the lower limbsDear Editor,
Leriche syndrome is a rare variant of atherosclerotic
occlusive disease characterized by total occlusion of
abdominal aorta and/or common iliac arteries.1 The anti-
phospholipid syndrome is a prothrombotic disorder that can
affect both venous and arterial thrombosis.2 Co-occurrence
of antiphospholipid syndrome and Leriche syndrome is
extremely rare. Here, we report a male patient with re-
fractory ulcers of the right foot; he received antibiotic
therapy and surgical debridement during hospitalization,
however, the ulcer wound did not heal well. The results of
image study and laboratory data finally proved the above
syndromes.
A 52-year-old male patient complained of chronic ulcer
wound of the right foot without any trauma history. He also
had claudication of the legs, body weight loss with a body
mass index of 17.6 kg/m2, and erectile dysfunction for
many years. The physical examination revealed that his
bilateral femoral pulses were absent. The extremities
showed bilateral lower legs muscle atrophy, and an ulcer
wound with peripheral tissue gangrene on the right foot and
barely palpable pulses of bilateral dorsalis pedis arteries.
He received empiric antibiotic therapy with oxacillin 2 g
intravenous drip q. 6 hours and gentamicin 80 mg intrave-
nous drip q. 12 hours for 7 days, and received local surgical
debridement. The aerobic and anaerobic culture all
revealed negative finding, however, the ulcer wound still
did not heal. Computed tomography and angiography
showed total occlusion of infrarenal abdominal aorta
(Figure 1), and bilateral common iliac arteries with subse-
quent collateral circulation. Many small collaterals vessels
were reconstituted in the bilateral lower extremities.
Antiphospholipid antibodies detected by enzyme-linked
immunosorbent assay showed 640 RU/mL (positive), and
the anticardiolipin immunoglobulin G detected by lupushttp://dx.doi.org/10.1016/j.jmii.2015.09.003
1684-1182/Copyright ª 2015, Taiwan Society of Microbiology. Publishedanticoagulant assays showed >160 mg/mL (positive). The
patient was diagnosed as Leriche syndrome co-occurring
with antiphospholipid syndrome. He was discharged with
a treatment plan for antiphospholipid syndrome and
recommendation to receive aorta and common iliac arterial
revascularization.
The diagnosis of Leriche syndrome includes a triad of
claudication, impotence, and absence of femoral pulses
due to chronic large blood vessels occlusion.1,3,4 Unlike
Kawasaki disease, which is caused by vasculitis of coronary
arteries,5 Leriche syndrome is due to the atherosclerotic
changes in the aorta or common iliac arteries.1e4 Anti-
phospholipid syndrome commonly involves the deep veins
of the lower limbs, the cerebral arterial circulation, and
placenta due to vascular thrombosis. However, any tissue
or large vascular bed can be affected.2,4 The term anti-
phospholipid antibodies include anti-b2-glycoprotein
detected by enzyme-linked immunosorbent assay or anti-
cardiolipin antibodies detected by lupus anticoagulant as-
says.2 A diagnosis of the antiphospholipid syndrome is made
if at least one of the above clinical criteria and one of the
laboratory criteria are met.2
Standard therapy of Leriche syndrome is surgical revas-
cularization. Keller et al1 reported a 56-year-old man with
co-occurrence of Leriche syndrome and dilated cardiomy-
opathy; the patient was successfully treated with antihy-
pertensive drugs, an implanted defibrillator, and surgical
reconstruction of the abdominal aorta. Toffon et al4 re-
ported a patient with lower limb ischemia due to aortoiliac
thrombosis related to antiphospholipid syndrome, and that
he has also successfully been treated with a combination of
medical and surgical therapy. The relationship of Leriche
and antiphospholipid syndrome has been unclear until now.
Clinicians should be aware that a refractory ulcers wound
of the lower limbs may be due to large vessel occlusion such
as Leriche syndrome.by Elsevier Taiwan LLC. All rights reserved.
Figure 1. (A) Computed tomography and (B) angiography of
the abdomen revealed total occlusion of infrarenal abdominal
aorta (arrow showing the site of occlusion) and bilateral com-
mon iliac arteries, with collateral circulation in the pelvic
cavity.
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